Oral Berotralstat Expanded Access Program

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

NCT05162066 ·Status: TERMINATED ·Phase: PHASE2

Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD

NCT05781516 ·Status: UNKNOWN ·Phase: NA

Monthly Dosing of Atacicept in IgAN

NCT07020923 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

NCT06868290 ·Status: RECRUITING ·Phase: PHASE2

The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia

NCT01507480 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis

NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Autoimmune and Autoinflammatory Genetics Study

NCT06004349 ·Status: RECRUITING

ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)

NCT05630612 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome

NCT05845723 ·Status: RECRUITING ·Phase: PHASE2

Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid

NCT03622801 ·Status: COMPLETED

The Registry Study of Takayasu Arteritis in East China

NCT03893136 ·Status: RECRUITING

Atacicept in Subjects With IgA Nephropathy

NCT04716231 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis

NCT02169219 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis

NCT01363388 ·Status: COMPLETED ·Phase: PHASE2

Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)

NCT03240991 ·Status: COMPLETED

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

NCT00685373 ·Status: COMPLETED ·Phase: PHASE3

Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

NCT06611696 ·Status: RECRUITING ·Phase: PHASE4

The Role of the Coagulation Pathways in Recurrent Angioedema

NCT02892682 ·Status: TERMINATED ·Phase: NA

Open-label Pilot Study of Abatacept for the Treatment of Vitiligo

NCT02281058 ·Status: UNKNOWN ·Phase: PHASE1

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

NCT00468208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome

NCT01730495 ·Status: TERMINATED ·Phase: PHASE2

Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy

NCT06982040 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Steroids and Methotrexate to Treat Systemic Vasculitis

NCT00001256 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome

NCT01197040 ·Status: COMPLETED ·Phase: PHASE3

Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis

NCT00441961 ·Status: COMPLETED ·Phase: NA